| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | SVP, Chief Medical Officer | SVP and Chief Medical Officer +1 more
3 companies
Burke Steven Keith is a SVP, Chief Medical Officer at AKBA, with reported holdings spanning 3 companies. Recent filings cover 2 purchases and 22 sales. Those positions are worth an estimated $1.3M at current prices.
Our model assigns Burke Steven Keith a middling insider score of 61/100, based on 15 past trades. Over a 12-month horizon, 46.7% of those trades were profitable, with an average 12-month return of +0.8%.
Burke Steven Keith's largest disclosed position is in AKBA as SVP, Chief Medical Officer, worth about $1.3M. The recent filings there lean toward selling, a net 276,268 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Medical Officer | Sell10b5-1 | 67,658 | $1.39 | $94,044.62 | -6.7% | +8.7% | - | |
| Mar 3, 2025 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Medical Officer | Sell10b5-1 | 7,144 | $1.83 | $13,073.52 | -0.9% | +80.6% | -32.5% | |
| Feb 3, 2025 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Medical Officer | Sell10b5-1 | 50,506 | $2.10 | $106,062.60 | -5.8% | +10.4% | -33.5% | |
| Feb 29, 2024 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Medical Officer | Sell | 7,169 | $1.58 | $11,327.02 | -1.0% | -34.8% | +17.1% | |
| Feb 27, 2024 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Medical Officer | Sell10b5-1 | 8,367 | $1.52 | $12,717.84 | -1.2% | -34.8% | +9.8% | |
| Feb 1, 2024 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Medical Officer | Sell | 24,311 | $1.68 | $40,842.48 | -3.3% | -27.5% | +31.0% | |
| Aug 25, 2023 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Medical Officer | Sell | 27,000 | $1.15 | $31,050.00 | -3.9% | -13.0% | +33.0% | |
| May 16, 2023 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Medical Officer | Sell | 63,567 | $1.07 | $67,889.56 | -10.7% | +25.7% | +12.4% | |
| Mar 1, 2023 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Medical Officer | Sell | 14,123 | $0.88 | $12,392.93 | -2.3% | +4.8% | +72.7% | |
| Feb 27, 2023 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Medical Officer | Sell | 7,539 | $0.81 | $6,130.71 | -1.2% | +17.5% | +101.1% |